Literature DB >> 16970763

Mutations in the NDP gene: contribution to Norrie disease, familial exudative vitreoretinopathy and retinopathy of prematurity.

Joanne L Dickinson1, Michèle M Sale, Abraham Passmore, Liesel M FitzGerald, Catherine M Wheatley, Kathryn P Burdon, Jamie E Craig, Supaporn Tengtrisorn, Susan M Carden, Hector Maclean, David A Mackey.   

Abstract

BACKGROUND: To examine the contribution of mutations within the Norrie disease (NDP) gene to the clinically similar retinal diseases Norrie disease, X-linked familial exudative vitreoretinopathy (FEVR), Coat's disease and retinopathy of prematurity (ROP).
METHODS: A dataset comprising 13 Norrie-FEVR, one Coat's disease, 31 ROP patients and 90 ex-premature babies of <32 weeks' gestation underwent an ophthalmologic examination and were screened for mutations within the NDP gene by direct DNA sequencing, denaturing high-performance liquid chromatography or gel electrophoresis. Controls were only screened using denaturing high-performance liquid chromatography and gel electrophoresis. Confirmation of mutations identified was obtained by DNA sequencing.
RESULTS: Evidence for two novel mutations in the NDP gene was presented: Leu103Val in one FEVR patient and His43Arg in monozygotic twin Norrie disease patients. Furthermore, a previously described 14-bp deletion located in the 5' unstranslated region of the NDP gene was detected in three cases of regressed ROP. A second heterozygotic 14-bp deletion was detected in an unaffected ex-premature girl. Only two of the 13 Norrie-FEVR index cases had the full features of Norrie disease with deafness and mental retardation.
CONCLUSION: Two novel mutations within the coding region of the NDP gene were found, one associated with a severe disease phenotypes of Norrie disease and the other with FEVR. A deletion within the non-coding region was associated with only mild-regressed ROP, despite the presence of low birthweight, prematurity and exposure to oxygen. In full-term children with retinal detachment only 15% appear to have the full features of Norrie disease and this is important for counselling parents on the possible long-term outcome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16970763     DOI: 10.1111/j.1442-9071.2006.01314.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  33 in total

Review 1.  Wnt Signaling in vascular eye diseases.

Authors:  Zhongxiao Wang; Chi-Hsiu Liu; Shuo Huang; Jing Chen
Journal:  Prog Retin Eye Res       Date:  2018-12-01       Impact factor: 21.198

Review 2.  Genetic susceptibility to retinopathy of prematurity: the evidence from clinical and experimental animal studies.

Authors:  Gerd Holmström; Peter van Wijngaarden; Douglas J Coster; Keryn A Williams
Journal:  Br J Ophthalmol       Date:  2007-12       Impact factor: 4.638

3.  A novel Norrie disease pseudoglioma gene mutation, c.-1_2delAAT, responsible for Norrie disease in a Chinese family.

Authors:  Xin-Yu Zhang; Wei-Ying Jiang; Lu-Ming Chen; Su-Qin Chen
Journal:  Int J Ophthalmol       Date:  2013-12-18       Impact factor: 1.779

4.  Wnt signaling mediates pathological vascular growth in proliferative retinopathy.

Authors:  Jing Chen; Andreas Stahl; Nathan M Krah; Molly R Seaward; Roberta J Dennison; Przemyslaw Sapieha; Jing Hua; Colman J Hatton; Aimee M Juan; Christopher M Aderman; Keirnan L Willett; Karen I Guerin; Akiko Mammoto; Matthew Campbell; Lois E H Smith
Journal:  Circulation       Date:  2011-10-03       Impact factor: 29.690

5.  Unilateral sporadic retinal dysplasia: results of histopathologic, immunohistochemical, chromosomal, genetic, and VEGF-A analyses.

Authors:  Frederick A Jakobiec; Fouad R Zakka; Robert D'Amato; Margaret M Deangelis; David S Walton; Rajesh C Rao
Journal:  J AAPOS       Date:  2011-12       Impact factor: 1.220

Review 6.  Retinopathy of prematurity: a review of risk factors and their clinical significance.

Authors:  Sang Jin Kim; Alexander D Port; Ryan Swan; J Peter Campbell; R V Paul Chan; Michael F Chiang
Journal:  Surv Ophthalmol       Date:  2018-04-19       Impact factor: 6.048

Review 7.  Current update on retinopathy of prematurity: screening and treatment.

Authors:  Jing Chen; Andreas Stahl; Ann Hellstrom; Lois E Smith
Journal:  Curr Opin Pediatr       Date:  2011-04       Impact factor: 2.856

8.  Genetic contributions to the development of retinopathy of prematurity.

Authors:  Shakir Mohamed; Kendra Schaa; Margaret E Cooper; Elise Ahrens; Ana Alvarado; Tarah Colaizy; Mary L Marazita; Jeffrey C Murray; John M Dagle
Journal:  Pediatr Res       Date:  2009-02       Impact factor: 3.756

9.  MAOA and mechanisms of panic disorder revisited: from bench to molecular psychotherapy.

Authors:  A Reif; J Richter; B Straube; M Höfler; U Lueken; A T Gloster; H Weber; K Domschke; L Fehm; A Ströhle; A Jansen; A Gerlach; M Pyka; I Reinhardt; C Konrad; A Wittmann; B Pfleiderer; G W Alpers; P Pauli; T Lang; V Arolt; H-U Wittchen; A Hamm; T Kircher; J Deckert
Journal:  Mol Psychiatry       Date:  2013-01-15       Impact factor: 15.992

10.  Laminins containing the β2 and γ3 chains regulate astrocyte migration and angiogenesis in the retina.

Authors:  Gopalan Gnanaguru; Galina Bachay; Saptarshi Biswas; Germán Pinzón-Duarte; Dale D Hunter; William J Brunken
Journal:  Development       Date:  2013-05       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.